Showing results (21-30 of 60) with videos related to
Sort By:
Pageof 6
Vaccine|October 21, 2018
Workshop report: Experimental animal models for universal influenza vaccinesFlavia D'Alessio, Gerrit Koopman, Sophie Houard, et al.Journal of Virology|September 29, 2006
Role of ran binding protein 5 in nuclear import and assembly of the influenza virus RNA polymerase complexTao Deng, Othmar G Engelhardt, Benjamin Thomas, et al.Plos One|August 2, 2014
The breadth of cross sub-type neutralisation activity of a single domain antibody to influenza hemagglutinin can be increased by antibody valencySimon E Hufton, Paul Risley, Christina R Ball, et al.Plos One|May 19, 2012
Permissible variation in the 3' non-coding region of the haemagglutinin genome segment of the H5N1 candidate influenza vaccine virus NIBRG-14 [corrected]Rachel E Johnson, Michelle Hamill, Ruth Harvey, et al.The Journal of General Virology|June 7, 2019
Segment 2 from influenza A(H1N1) 2009 pandemic viruses confers temperature-sensitive haemagglutinin yield on candidate vaccine virus growth in eggs that can be epistatically complemented by PB2 701DSaira Hussain, Matthew L Turnbull, Rute M Pinto, et al.Vaccine|October 12, 2010
Improved haemagglutinin antigen content in H5N1 candidate vaccine viruses with chimeric haemagglutinin moleculesRuth Harvey, Carolyn Nicolson, Rachel E Johnson, et al.Scientific Reports|February 5, 2021
Nanobodies mapped to cross-reactive and divergent epitopes on A(H7N9) influenza hemagglutinin using yeast displayTiziano Gaiotto, Walter Ramage, Christina Ball, et al.Vaccine|October 10, 2020
Protective efficacy of a polyvalent influenza A DNA vaccine against both homologous (H1N1pdm09) and heterologous (H5N1) challenge in the ferret modelKate Guilfoyle, Diane Major, Sarah Skeldon, et al.Influenza and Other Respiratory Viruses|October 30, 2019
Biosafety risk assessment for production of candidate vaccine viruses to protect humans from zoonotic highly pathogenic avian influenza virusesLi-Mei Chen, Ruben O Donis, David L Suarez, et al.Antibodies (Basel, Switzerland)|September 24, 2019
Cross-Reactive and Lineage-Specific Single Domain Antibodies against Influenza B HemagglutininWalter Ramage, Tiziano Gaiotto, Christina Ball, et al.Pageof 6